Abbott India Limited Share Price NSE India S.E.

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:51 17/05/2024 pm IST 5-day change 1st Jan Change
26,491 INR -0.19% Intraday chart for Abbott India Limited +3.63% +15.93%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 58.49B 702M Sales 2025 * 64.7B 777M Capitalization 563B 6.76B
Net income 2024 12.01B 144M Net income 2025 * 13.12B 158M EV / Sales 2024 9.79 x
Net cash position 2024 * 22.66B 272M Net cash position 2025 * 21.47B 258M EV / Sales 2025 * 8.37 x
P/E ratio 2024
47.7 x
P/E ratio 2025 *
42.9 x
Employees 3,700
Yield 2024 *
1.11%
Yield 2025 *
1.35%
Free-Float 24.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.19%
1 week+3.63%
Current month+0.17%
1 month+1.33%
3 months-10.32%
6 months+13.73%
Current year+15.93%
More quotes
1 week
26 051.75
Extreme 26051.75
27 216.50
1 month
25 200.00
Extreme 25200
27 216.50
Current year
22 761.10
Extreme 22761.1
29 638.95
1 year
20 605.05
Extreme 20605.05
29 638.95
3 years
15 514.00
Extreme 15514
29 638.95
5 years
7 404.00
Extreme 7404
29 638.95
10 years
1 707.05
Extreme 1707.05
29 638.95
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01/95/01
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 01/19/01
Chairman 81 01/68/01
Director/Board Member 67 01/96/01
More insiders
Date Price Change Volume
17/24/17 26,491 -0.19% 5,257
16/24/16 26,543 +0.50% 10,430
15/24/15 26,411 -1.37% 6,434
14/24/14 26,778 -1.11% 8,340
13/24/13 27,080 +2.69% 17,401

Delayed Quote NSE India S.E., May 17, 2024 at 05:13 pm IST

More quotes
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW